SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / MedicalImmunomedics (IMMU) - moderated


Previous 10 Next 10 
To: trickydick who wrote (53366)12/6/2019 11:49:23 PM
From: EMU2
   of 54054
 
Idaho is ALWAYS HONEST. I don't see anyone being made liars of on here.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


From: EMU212/6/2019 11:56:54 PM
7 Recommendations   of 54054
 
I don't get it. Those who are hoping for a sale of IMMU sooner than later are the same ones who pucker up with a stock offering to fill the coffers. No one is crazy about dilution, but little cash on hand is not a good negotiating position for the sellers.

Share RecommendKeepReplyMark as Last Read


To: trickydick who wrote (53352)12/7/2019 2:58:55 AM
From: ghettogoulash
2 Recommendations   of 54054
 
Why yes, I did. Six weeks ago when we were priced at $15.44, after a modest run-up. The dilution was a surprise, though.


I do not believe that very much is "built in" at this point. Resubmission should remove 50% of the uncertainty and propel $20 per share. AA Approval I see $25 minimum.


Message 32377246

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: ghettogoulash who wrote (53377)12/7/2019 4:11:58 AM
From: ghettogoulash
   of 54054
 
Disclosure: we could sell off $2 next week. I have no idea. But I still maintain $20 by AA readout. The short position is a non-factor to me. We had a colossal short position at $2 with almost no downside. Makes no sense. I have theorized that a bulk of that is probably market makers short their own inventories-- with an escape hatch. Most likely some collusion going on here in a game with no oversight in which only 50-70% of trades even cross the ticker. Nothing else makes sense.

Share RecommendKeepReplyMark as Last ReadRead Replies (2)


To: ghettogoulash who wrote (53378)12/7/2019 4:59:53 AM
From: ghettogoulash
   of 54054
 
We had a colossal short position at $2 with almost no downside.

What we have now pales in comparison. There was almost no downside at $2. Consider also that the shorts are paying interest (10%?) on those borrowed shares. A market maker short his own inventory, I would think, would not be paying interest on those shorts.

Share RecommendKeepReplyMark as Last Read


From: galt12/7/2019 6:52:08 AM
2 Recommendations   of 54054
 
As stated numerous times, the shares are now trading, as expected, with some overreach due to hedge positions and shorts. We should get back to the $28 level BY or WITH AA BlA Readout acceptance, setting the shares up for a move into the 30's or higher upon final approval of the science. Yes, biotech and small cap run is helping, and should continue to help now that Santa Claus is here. Best not to trade this now. In fact, my final trading shares were sold yesterday. I moved some to my core position, which will not be touched until we get the FDA acceptance of BLA and/or the stock trades in the $28 level. I'll then sell 1/3rd, giving me a very nice profit and putting me back to my original core position of share count. Oh, by the way, thank you Santa. Hope we've now put the nervous Nellie's in the back room and the negative Karma posters into the pasture. Yes, we will see some short term up and down, as with most stocks that built up such a large option position and naked shorts. Of course, watch out for unexpected moves that the boogie man might make. He/She is a crafty b....... All asset classes are overvalued, IMO, and we would fall some with a general market downturn. No reading on a buyout, and, at this point, who cares about speculating on this. It will be what it will be and we have no influence on it or knowledge. What we know is that the science is to our liking, those in need of it are wanting, and the run in the stock, to date, has been very good to those that traded it or took advantage of it to increase their positions. Hope Santa comes to all and the boogie man is overcome by the powers of good that surround this science.
Ahhh, you ask, what is his intent. Not saying, as now is the season to be jolly, Fa La La La La. Done.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: galt who wrote (53380)12/7/2019 9:14:02 AM
From: zevenhuizen
   of 54054
 
I sold all my trading shares and think I can buy back again.This was quite a big move with very decent volume past two days. In case I lost these trading shares , no big deal because it only means things are going well! And we are only talking small positions here since I am not a big time investor. I know one thing. Wall Street is buddies buddies and the ones paying in the end are the retail investors so besides IMMU, NRZ and some very good Reit's I do not have any positions and wait for the inevitable market fallback which is based on free printed money.

Share RecommendKeepReplyMark as Last Read


To: Karuna1 who wrote (53374)12/7/2019 9:30:54 AM
From: erickerickson
   of 54054
 
"...then the volume dry up, it will slide down below the offer price at least for..."

Yeah, but it's different now, this time I'm sure of it ;).

Still, I'll take a temporary pop then a dip over a sharp drop that stays down. Which I've also seen in the past. With this stock.

Kidding aside, what could make it different this time is if there really is an institutional demand that wasn't satisfied by this offering. If Captain B. has convinced fund managers that this is "The best last chance to buy at these low, low prices!" then this could well be the exception to your observation.

That said, I haven't a clue, just hope. We'll know more in January as you say...

As for the timing I have several theories:

1. we know we'll need more cash before we're profitable, let's do it now on the heels of the good news we'd re-filed when we know we can get $17.50. A bird in the hand...

2. there'll be an announcement Real Soon Now that requires a major outlay of cash.

3. we tend to think that they could do this quickly at any time, so one argument is "they should have let the price run up over the next few months and done it then". That has two assumptions, (a) that the price will run up and (b) institutions would be willing to step up to the plate whenever IMMU decided to make the offer. (a) is uncertain at best and (b) I haven't a clue. So my third theory is that the institutions put conditions on buying, anything from "within 10 days of resubmission" to "before the end of the year" to "only if it's under $20" to ???

4. IMMU isn't confident the market will stay at these levels and decided the risk of a market meltdown torpedoing the PPS was too great.

5. they expect more delays. I don't believe this for a second mind you and it would be hugely disappointing.

6. they need enough money to advance other parts of the pipeline before selling the company for a bazillion dollars in, say, the next year.

7. about 50 other possibilities.

Unless we take Dr. Aghazadeh out and pour enough wine down his throat to that his professionalism slips, we won't know all the factors that went into the timing. It really comes down to trust. "You should raise money when you can, and not when you need to" etc.

Enough musing for a Saturday morning, I have some things I need to get done around the house.

Share RecommendKeepReplyMark as Last ReadRead Replies (2)


From: trickydick12/7/2019 9:37:17 AM
   of 54054
 
Another thought crossed my feeble brain. Now that submission is done and virtually all commentary is more positive, would the people working for IMMU see the finish line and are racing to the finish and now buying into the company? Are there enough people in the market who have been following IMMU for years and have now made their move? The trading volume has been very strong over the past week, much of which was due to the submission, but, are the people who have been on the side lines have now moved in? Are there enough of these people to influence the price movement? Have institutional investors seen the risk factor go down dramatically? I agree we're on an upward trajectory, it's just those bumps in the road! Trying to get a more thoughts. It's been a long, agonizing struggle, but, the finish line is in sight. What a Christmas present it would be to get FDA approval by the time Santa is flying about delivering presents. Approval would be like getting that perfect gift you always wanted as a child. Hope upon hope!

Share RecommendKeepReplyMark as Last Read


To: erickerickson who wrote (53382)12/7/2019 10:44:02 AM
From: EMU2
   of 54054
 
My hope is #6 and the bazillian, even though it had a red line under it when I typed it. ;)

Share RecommendKeepReplyMark as Last ReadRead Replies (1)
Previous 10 Next 10